Excitement is in the air as Apple enthusiasts in New Zealand and Australia receive their pre-orders for the iPhone 17, Apple Watch Series 11, and AirPods Pro 3. With vibrant colors and impressive features, these devices are taking the tech world by storm. Find out more about these launches and pricing details!
The iPhone 17, iPhone 17 Pro, Pro Max, and iPhone Air are set to hit stores on September 19, and Apple has begun notifying customers that their devices have shipped. Check your order status now!
The expiration of the de minimis rule means that low-cost goods entering the U.S. will now face import taxes, impacting consumers, shippers, and small businesses dramatically. Discover how these changes affect your shopping experience!
The US has ended a crucial tariff exemption that allowed low-cost imports, impacting millions of shipments daily. Experts warn of rising prices and reduced options for American shoppers as businesses scramble to adapt.
The end of a 1930s US trade provision is reshaping global e-commerce. Discover how this change is affecting shipping, costs, and international trade dynamics under Trump’s administration.
The end of the de minimis exemption on small packages is here, leading to potential billions in new fees for consumers. Many postal services are halting shipments to the U.S., causing disruption in online shopping.
Major European parcel companies like DHL and Royal Mail are suspending shipments to the U.S. due to new tariff policies. Discover how these changes might affect your online shopping!
In a daring strategy to dominate the EV market, BYD has launched a fleet of massive ships to deliver vehicles worldwide, positioning itself to overtake Tesla in sales. Discover how this innovative approach is reshaping the automotive landscape!
Return fraud is on the rise as consumers exploit lax policies to their advantage. Small businesses are feeling the pressure, with many facing significant losses. Learn how this trend is reshaping the retail landscape.
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
